Akèy › Myelofibroz › Washington
Etid klinik pou Myelofibroz nan Washington, DC
4 etid pou Myelofibroz ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Ap rekriteFaz 3
- American Oncology Partners PA Center for Cancer and Blood Disorders, Bethesda · 7 mi lwen
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Ap rekriteFaz 3
- MedStar Georgetown University Hospital, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi lwen
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi lwen
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Ap rekriteFaz 3
- MedStar Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington D.C.
- The Center for Cancer and Blood Disorders, Bethesda · 7 mi lwen
Etid Myelofibroz nan lòt vil
- Houston, TX19 etid
- New York City, NY18 etid
- Boston, MA12 etid
- Durham, NC12 etid
- Seattle, WA11 etid
- Columbus, OH11 etid
- Miami, FL10 etid
- Salt Lake City, UT10 etid
- Nashville, TN9 etid
- Baldwin Park, CA9 etid
- Atlanta, GA9 etid
- Tampa, FL9 etid
Lòt etid nan Washington
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete46 etid
- Kansè Metastatik43 etid
- Kansè poumon41 etid
- Kansè pwostat38 etid
- Obèsite33 etid
- Kansè kolorektal29 etid
- Maladi kadyovaskilè28 etid
- Kansè vejik26 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.